Skip to main content
editorial
. 2019 Mar 15;8(1):13–23. doi: 10.1007/s40120-019-0129-0

Table 3.

DMD ranking on convenience attributes by experts (higher scores indicate better ranking)

Convenience attributes Scoring
Cladribine tablets Fingolimod Natalizumab Ocrelizumab Alemtuzumab
Convenient route and dosing schedule 8.7 8.0 7.5 7.8 8.1
Good patient compliance 8.0 7.3 8.0 7.8 8.3
Low monitoring burden 8.0 6.7 7.5 7.2 5.9

DMD disease-modifying drug